FDA issues new draft guidance on data monitoring committees

Regulatory NewsRegulatory NewsBiologics/ biosimilars/ vaccinesClinical TrialsCombination products/companion diagnosticsDiagnostics/IVDsMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited States